Joseph Wolk
Director of Finance/CFO bij JOHNSON & JOHNSON
Vermogen: 11 M $ op 29-02-2024
Profiel
Joseph J. Wolk bekleedt de functie van Chief Financial Officer & Executive Vice President bij Johnson & Johnson. De heer Wolk is tevens lid van de Cnbc Global Cfo Council. De heer Wolk behaalde zijn doctoraal aan de St. Joseph's University en zijn doctoraal aan de Temple University Beasley School of Law.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
JOHNSON & JOHNSON
0.00% | 15-02-2024 | 70 938 ( 0.00% ) | 11 M $ | 29-02-2024 |
KENVUE, INC.
0.00% | 23-08-2023 | 538 ( 0.00% ) | 10 222 $ | 29-02-2024 |
Actieve functies van Joseph Wolk
Bedrijven | Functie | Begin |
---|---|---|
JOHNSON & JOHNSON | Director of Finance/CFO | 01-07-2018 |
KENVUE INC. | Director/Board Member | 08-05-2023 |
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Corporate Officer/Principal | - |
Stanford University School of Medicine | Corporate Officer/Principal | - |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Corporate Officer/Principal | - |
St. Joseph's University | Director/Board Member | - |
Eerdere bekende functies van Joseph Wolk
Bedrijven | Functie | Einde |
---|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director of Finance/CFO | 01-01-2016 |
Opleiding van Joseph Wolk
St. Joseph's University | Undergraduate Degree |
Temple University Beasley School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
KENVUE INC. | Consumer Non-Durables |
Bedrijven in privébezit | 3 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Commercial Services |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Commercial Services |